Results 151 to 160 of about 691,577 (343)
Enhanced In Situ Bioremediation in Source Zones
In situ bioremediation (ISB) can be a low-cost approach for accelerating remediation timelines at sites impacted with dense non-aqueous phase liquids (DNAPLs) such as trichloroethene (TCE) and tetrachloroethene (PCE).
Michaye McMaster +4 more
doaj
A systematic review on the birth prevalence of metachromatic leukodystrophy
Background Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency in arylsulfatase A (ASA) activity arising primarily from ASA gene (ARSA) variants. Late-infantile, juvenile and adult clinical subtypes
Shun-Chiao Chang +4 more
doaj +1 more source
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu +5 more
wiley +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Population screening by Guthrie test for phenylketonuria in South-east Scotland. Report by the consultant paediatricians and medical officers of health of the S.E. Scotland Hospital Region. [PDF]
openalex +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source
Recently many corporations, organizations, and governmental agencies are putting a greater emphasis on evaluating sustainability of projects and products to help guide implementation and production.
Matt Vanderkooy +3 more
doaj
Between exploitation and control – Clients’ conceptions of the consultant-client relationship [PDF]
During the past years, the use of management consultants has increased significantly, giving managers repeated experiences of both hiring and working with them.
Pemer, Frida, Werr, Andreas
core

